Prostate Specific Antigen News and Research

RSS
Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence

PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence

Study shows the prevalence of low-value prostate cancer screening in primary care clinics

Study shows the prevalence of low-value prostate cancer screening in primary care clinics

Rising Medicare costs linked to increased use of new prostate cancer therapies

Rising Medicare costs linked to increased use of new prostate cancer therapies

Cambridge scientists develop a comprehensive tool for predicting individual's risk of prostate cancer

Cambridge scientists develop a comprehensive tool for predicting individual's risk of prostate cancer

Study identifies risk factors that increase Black men's susceptibility to early-onset prostate cancer

Study identifies risk factors that increase Black men's susceptibility to early-onset prostate cancer

Study shows benefits of metastasis-directed therapy without ADT for oligorecurrent prostate cancer

Study shows benefits of metastasis-directed therapy without ADT for oligorecurrent prostate cancer

Polygenic hazard score could be effective for predicting genetic risk of lethal prostate cancer

Polygenic hazard score could be effective for predicting genetic risk of lethal prostate cancer

$38,398 for a single shot of a very old cancer drug

$38,398 for a single shot of a very old cancer drug

More intensive prostate cancer screening may reduce the risk of metastatic cancer later

More intensive prostate cancer screening may reduce the risk of metastatic cancer later

Final results of the PATHFINDER study by GRAIL on multi-cancer early detection tests announced

Final results of the PATHFINDER study by GRAIL on multi-cancer early detection tests announced

Neoadjuvant NHAs followed by surgery can improve key outcomes in high-risk prostate cancer patients

Neoadjuvant NHAs followed by surgery can improve key outcomes in high-risk prostate cancer patients

New study supports targeted screening program for prostate cancer

New study supports targeted screening program for prostate cancer

Combined treatment approach proves to be beneficial for prostate cancer patients

Combined treatment approach proves to be beneficial for prostate cancer patients

Henry Ford Health offers a non-surgical treatment option for localized prostate cancer

Henry Ford Health offers a non-surgical treatment option for localized prostate cancer

Study uncovers new regulator of prostate cancer metastasis

Study uncovers new regulator of prostate cancer metastasis

Less PSA testing minimizes overdiagnosis but may lead to increase in metastatic prostate cancer cases

Less PSA testing minimizes overdiagnosis but may lead to increase in metastatic prostate cancer cases

New findings could change treatment practice and lengthen survival for men with pN1 prostate cancer

New findings could change treatment practice and lengthen survival for men with pN1 prostate cancer

Rise in metastatic prostate cancer coincides with recommendations against routine screenings

Rise in metastatic prostate cancer coincides with recommendations against routine screenings

New multi-marker risk algorithm could improve the accuracy of prostate cancer screening

New multi-marker risk algorithm could improve the accuracy of prostate cancer screening